Piya Chaemsaithong

Title: Innovations by Piya Chaemsaithong

Introduction

Piya Chaemsaithong is an accomplished inventor based in Hong Kong, China. He has made significant contributions to the field of medical diagnostics, particularly in the areas of labor prediction and preeclampsia risk assessment. With a total of six patents to his name, his work has the potential to greatly impact maternal health.

Latest Patents

Piya's latest patents include innovative kits and methods designed to distinguish between false labor and true labor. These kits utilize differences in the abundance and rate of change of specific biomarkers, such as B7-H2, SORC2, TF, C1-Esterase Inhibitor, Ran, IMDH1, and PGAM1, to accurately identify true labor. Additionally, he has developed kits and methods for predicting and treating preeclampsia. This involves a panel of biomarkers, including MMP-7 and gpIIbIIIa, which can predict the risk of preeclampsia when biological samples are obtained between the 16th and 22nd week of pregnancy. Later predictions can be made using a combination of Siglec-6, Activin A, ALCAM, and FCN2.

Career Highlights

Piya has worked with prestigious institutions such as Wayne State University and the National Institutes of Health, which is a component of the U.S. Department of Health & Human Services. His experience in these organizations has allowed him to collaborate on groundbreaking research and innovations.

Collaborations

Piya has collaborated with notable colleagues, including Adi L Tarca and Tinnakorn Chaiworapongsa. These partnerships have contributed to the advancement of his research and the development of his patented technologies.

Conclusion

Piya Chaemsaithong's contributions to medical diagnostics through his innovative patents demonstrate his commitment to improving maternal health. His work in distinguishing true labor from false labor and predicting preeclampsia risk showcases the importance of research and innovation in healthcare.